Constitution and Bylaws

Bylaws

Chapter I—The President

Section 1

The President shall preside at all meetings of The United States Pharmacopeial Convention, hereinafter referred to in these Bylaws as the Pharmacopeial Convention. In the absence of the President or in the event of his or her inability to preside, a President pro tempore, to be appointed by the Board of Trustees, shall conduct the meeting.

Section 2

The presiding officer shall present an address at the stated meeting.

Section 3

The presiding officer shall have the right to call a member to the chair in order that he or she may take the floor in debate.

Section 4

Not later than six months before the stated meeting of the Pharmacopeial Convention, the President shall appoint, subject to the advice and consent of the Board of Trustees, five members of the Convention as a Nominating Committee for Officers and Trustees, two of whom shall be members of the Board of Trustees. Of the members appointed from the Board of Trustees, one shall be representative of the pharmaceutical sciences and one shall be representative of the medical sciences.

Section 5

The President shall appoint, with the advice and consent of the Board of Trustees, five members of the Convention to serve on the Nominating Committee for the Council of Experts, none of whom shall be members of the Council of Experts, Expert Committees, the Board of Trustees, salaried employees, nor officers of the Pharmacopeial Convention.

Section 6

The President shall appoint all committees of the Convention not otherwise provided for in these Bylaws.

Section 7

Not later than one year prior to the stated meeting of the pharmacopeial Convention, the President, through the Secretary, shall mail a notice of the meeting to all members and a request to prepare for the authorization of a delegate where none has been appointed to each of those organizations eligible for representation under the Constitution. He or she shall mail a second notice of the meeting to all members and the request for the authorization of a delegate where none has been appointed and an alternate delegate not later than six months prior to the stated meeting. He or she shall also request medical, pharmaceutical, and other appropriate journals to publish the announcement of the said meeting.

Section 8

The President shall be a member, ex officio, of the Board of Trustees and of all committees except the Council of Experts and its Expert Committees.

Section 9

The President shall serve for one elected term of five years and act as President until his or her successor shall have been elected and installed.

Section 10

In the event of a vacancy in the office of President, the Board of Trustees shall, from the membership of the Pharmacopeial Convention, select a President.

Section 11

In the event of a temporary disability or absence of the President, or inability to perform his or her duties, an acting President may be appointed from the membership of the Pharmacopeial Convention by the Board of Trustees to act in the place of the President.